Hyphens Pharma - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/04/20	DMG & Partners	Hyphens Pharma	0.23	0.27	Buy	DCF
05/15/20	DMG & Partners	Hyphens Pharma	0.24	0.27	Buy	DCF
07/20/20	Phillip	Hyphens Pharma	0.42	0.435	Accumulate	DCF
08/20/20	Phillip	Hyphens Pharma	0.45	0.495	Accumulate	DCF
11/09/20	Amfrasers	Hyphens Pharma	0.405	0.48	Buy	PER17x FY21
11/16/20	Phillip	Hyphens Pharma	0.345	0.365	Accumulate	DCF

Hutchison Port - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/11/20	DBS Vickers	Hutchison Port	0.161	0.17	Hold
06/02/20	DBS Vickers	Hutchison Port	0.112	0.12	Hold	DCF
08/06/20	DBS Vickers	Hutchison Port	0.102	0.14	Buy	DCF
09/07/20	DBS Vickers	Hutchison Port	0.106	0.14	Buy
11/03/20	DBS Vickers	Hutchison Port	0.142	0.14	Buy
11/18/20	DBS Vickers	Hutchison Port	0.152	0.22	Buy	DCF
01/06/21	DBS Vickers	Hutchison Port	0.198	0.22	Buy

HRnetGroup - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/28/20	DBS Vickers	HRnetGroup	0.58	0.63	Hold	PER10x FY20, Ex-cash
03/02/20	DMG & Partners	HRnetGroup	0.56	0.61	Neutral	PER12x FY20
06/25/20	CIMB	HRnetGroup	0.5	0.58	Hold
08/13/20	DBS Vickers	HRnetGroup	0.48	0.5	Hold	PER7.5x FY20, Ex-cash
08/13/20	DMG & Partners	HRnetGroup	0.48	0.52	Neutral	DCF
09/17/20	CIMB	HRnetGroup	0.445	0.523	Add
10/29/20	DMG & Partners	HRnetGroup	0.48	0.52	Buy	DCF
12/09/20	CIMB	HRnetGroup	0.51	0.635	Add	PER13.2x FY22

Stock calls for 15 January 2021

Date	Analyst	Company	Last	Target	Call	Valuation
01/15/21	DMG & Partners	First Resources	1.63	1.9	Buy
01/15/21	CIMB	GKE	0.138	0.184	Add	Sum of parts
01/15/21	Jefferies	Ifast Corp	4.28	4.35	Buy
01/15/21	OCBC	SIA	4.35	3.7	Sell
01/15/21	Kim Eng	SPH Reit	0.86	0.8	Hold	DDM

Is Sinovac's vaccine so lousy? - Part 2

https://www.globaltimes.cn/page/202101/1212746.shtml

Omg! Pfizer's vaccine has as low as 19% efficacy if it follows Sinovac's standard.

It turns out that Pfizer has not released its raw data for peer reviews to verify its efficacy and it can include or exclude any test subject for its assessment.

Like I said before, pharmaceutical companies will make false claims just to sell their drugs.

http://sg-stock.blogspot.com/2021/01/pharmaceutical-companies-will-make.html

Is Sinovac's vaccine so lousy?

Well, I am a staunch believer in the saying, the devil lies in the details, and have conducted my own research on Sinovac's vaccine efficacy.

I will reveal what I've found out for the newly published low efficacy rate (50.4%).

https://fortune.com/2021/01/13/sinovac-vaccine-efficacy-rate-drop/

It turns out that Sinovac has more stringent and comprehensive trials conducted in Brazil compared to other vaccine manufacturers.

Sinovac's efficacy included many mild and asymptomatic subjects but other vaccine manufacturers didn't count these subjects as infected cases in their trials which explained the much higher efficacy rates.  Furthermore, Sinovac's trials included a lot of high-risk subjects (healthcare workers) compared to the US & UK trials.

However, Sinovac and Astrazeneca have a 100% efficacy rate against severe covid which is the most important because this will mean we won't end up in the hospitals.

Astrazeneca's vaccine has only 62% efficacy when injected with 2 full doses but has 100% efficacy against severe covid.

https://www.abc.net.au/news/2021-01-13/government-coronavirus-vaccine-rollout-astrazeneca-efficacy/13053302

No matter what, it is still best to be vaccinated because this will protect us from getting a severe covid.  However, the immunity might only be temporary (5 months) as stipulated in the latest UK research.

https://www.reuters.com/article/health-coronavirus-immunity/covid-19-infection-gives-some-immunity-for-at-least-5-months-uk-study-finds-idUSL8N2JO4MM

What will I choose then?

Well, I will choose the upcoming J&J's vaccine because it only requires 1 injection and this means that I will only need to suffer the side effects once instead of twice for other vaccines.

https://www.cnbc.com/2021/01/13/covid-vaccine-johnson-johnson-one-shot-safe-generates-immune-response.html

HRnetGroup - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/28/20	CIMB	HRnetGroup	0.58	0.58	Hold
02/28/20	DBS Vickers	HRnetGroup	0.58	0.63	Hold	PER10x FY20, Ex-cash
03/02/20	DMG & Partners	HRnetGroup	0.56	0.61	Neutral	PER12x FY20
06/25/20	CIMB	HRnetGroup	0.5	0.58	Hold
08/13/20	DBS Vickers	HRnetGroup	0.48	0.5	Hold	PER7.5x FY20, Ex-cash
08/13/20	DMG & Partners	HRnetGroup	0.48	0.52	Neutral	DCF
09/17/20	CIMB	HRnetGroup	0.445	0.523	Add
10/29/20	DMG & Partners	HRnetGroup	0.48	0.52	Buy	DCF
12/09/20	CIMB	HRnetGroup	0.51	0.635	Add	PER13.2x FY22

Hongkong Land - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/06/20	DBS Vickers	Hongkong Land	5.05	5.81	Buy	RNAV (50% discount)
03/10/20	CIMB	Hongkong Land	4.55	6.05	Add
05/05/20	DBS Vickers	Hongkong Land	4.13	5.22	Buy	RNAV (55% discount)
07/30/20	Lim & Tan	Hongkong Land	3.72	0	Buy
07/30/20	DBS Vickers	Hongkong Land	3.72	4.94	Buy	RNAV (55% discount)
08/03/20	DBS Vickers	Hongkong Land	3.79	4.8	Buy	RNAV (55% discount)
08/03/20	CIMB	Hongkong Land	3.79	5.1	Add
09/15/20	Lim & Tan	Hongkong Land	3.8	0	Buy
10/16/20	Lim & Tan	Hongkong Land	3.79	0	Buy
12/02/20	CIMB	Hongkong Land	4.19	5.1	Add

Hong Leong Asia - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
01/28/20	Lim & Tan	Hong Leong Asia	0.625	0	Buy on weakness

Stock calls for 14 January 2021

Date	Analyst	Company	Last	Target	Call	Valuation
01/14/21	DMG & Partners	ARA Logistics	0.67	0.74	Buy
01/14/21	UOB Kay Hian	First Resources	1.69	1.85	Buy
01/14/21	UOB Kay Hian	Food Empire	0.75	0.88	Buy
01/14/21	Lim & Tan	GL Ltd	0.56	0	Hold
01/14/21	CIMB	Ifast Corp	3.95	4.15	Hold	PER37x FY22
01/14/21	UOB Kay Hian	SIA	4.35	3.8	Sell	PB0.9x FY22
01/14/21	DMG & Partners	ST Engineering	3.88	4.4	Buy
01/14/21	Kim Eng	Wilmar	5.05	6.8	Buy	DCF & PER44x

The US inflation is coming - Part 7

https://sg.finance.yahoo.com/news/feds-bullard-sees-inflation-rising-160403236.html

St. Louis Fed sees inflation rising!

We had also reported this a week ago.

http://sg-stock.blogspot.com/2021/01/the-us-inflation-is-coming-part-3.html

Let's recap:

1. Oil price is rising.

2. USD index is declining.

3. PMI prices are rising.

4. Freight costs are rising

5. Food prices are rising.

All of these factors are causing inflation.

http://www.fao.org/worldfoodsituation/foodpricesindex/en/

Ho Bee - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
09/14/20	CIMB	Ho Bee	2.19	2.7	Add	Up from $2.56
10/20/20	UOB Kay Hian	Ho Bee	2.28	3.32	Buy	RNAV (40% discount)

Hi-P - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/14/20	DBS Vickers	Hi-P	1.3	1.37	Hold	PER14x FY20
02/18/20	Kim Eng	Hi-P	1.31	1	Sell	PB1.2x FY20
03/30/20	Kim Eng	Hi-P	0.83	0.78	Hold	Roe-g/Coe-g, PB1x FY20
04/02/20	DBS Vickers	Hi-P	0.835	0.85	Hold
04/20/20	Kim Eng	Hi-P	0.97	0.78	Neutral	PB1x FY20
08/03/20	Kim Eng	Hi-P	1.28	1.23	Hold	PB1.4x FY21
08/03/20	DBS Vickers	Hi-P	1.28	1.34	Hold	PER13x FY21
08/03/20	UOB Kay Hian	Hi-P	1.28	1.11	Sell
09/09/20	CIMB	Hi-P	1.18	1.23	Hold	PB1.52x FY20
09/30/20	Kim Eng	Hi-P	1.13	1.23	Buy	PB1.4x FY21
10/05/20	CIMB	Hi-P	1.14	1.23	Hold
12/21/20	Kim Eng	Hi-P	2	1.23	Sell	Accept offer price of $2
12/21/20	Lim & Tan	Hi-P	2	2	Accept Offer	offer price @ $2

Guocoland - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
08/25/20	Lim & Tan	Guocoland	1.4	0	Accumulate

Stock calls for 13 January 2021

Date	Analyst	Company	Last	Target	Call	Valuation
01/13/21	Kim Eng	AEM	3.84	5.05	Buy
01/13/21	CIMB	AEM	3.84	4.63	Add
01/13/21	Kim Eng	Frencken	1.34	1.39	Buy
01/13/21	Macquarie	Genting	0.87	0.95	outperform	EV/Ebitda
01/13/21	Amfrasers	Innotek	0.65	0.73	Outperform	EV/Ebita0.5x
01/13/21	DMG & Partners	Oxley	0.235	0.27	Buy
01/13/21	CIMB	Riverstone	1.41	2.5	Add
01/13/21	Aminvestment	Top Glove	2.18	2.13	Hold	Ringgit target $6.50
01/13/21	Kim Eng	UMS	1.2	1.41	Buy
01/13/21	Kim Eng	Venture	19.96	23.27	Buy
01/13/21	UOB Kay Hian	Wilmar	5.08	6.4	Buy

Hot news: The Brazil covid variant could reinfect ex-covid patient.

https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584

A Brazilian was reinfected with covid containing the E484K spike protein mutation in less than 6 months.

This is bad news for mankind because the patient's immunity cannot recognize the mutated E484K spike protein.

It seems that our existing vaccines are produced to recognize the N502Y spike protein but not the E484K spike protein.

Let's wait for scientists to confirm this.

Great Eastern - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/21/20	Citibank	Great Eastern	22.15	27	Buy
03/18/20	Citibank	Great Eastern	18.2	19.5	Hold